ANABV · Categories · Form 4
ANABV - SEC Form 4 insider transactions
AnaptysBio Inc. (ANABV) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for ANABV
- Director Renton Hollings exercised 5,000 shares at a strike of $18.03 and sold $249,372 worth of shares (5,000 units at $49.87) as part of a pre-agreed trading plan (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Orwin John A converted options into 1,300 shares, increasing direct ownership by 8% to 17,995 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Lizzul Paul F.4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by President, CEO Faga Daniel4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Schmid John P. converted options into 6,030 shares, increasing direct ownership by 19% to 37,652 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Orwin John A converted options into 6,030 shares, increasing direct ownership by 57% to 16,695 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Renton Hollings converted options into 6,030 shares, increasing direct ownership by 121% to 10,995 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Director Hughes Owen4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Murphy Christopher M.4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Director Gray Susannah4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Amendment: SEC Form 4 filed by President, CEO Faga Daniel4/A - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Orwin John A4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Schmid John P.4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Renton Hollings4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Faga Daniel4 - ANAPTYSBIO, INC (0001370053) (Issuer)